Literature DB >> 3116920

Pharmacokinetics and therapeutic efficacy of gentamicin in an experimental pleural empyema rabbit model.

I Shohet1, A Yellin, J Meyerovitch, E Rubinstein.   

Abstract

The pharmacokinetics and therapeutic efficacy of gentamicin were investigated in an experimental pleural empyema rabbit model. Pleural effusion was induced by the intrapleural administration of turpentine, and empyema was induced by direct inoculation of the effusion with Klebsiella pneumoniae. Pleural empyema compared with effusion was characterized by lower pH, oxygen tension (PaO2), and glucose levels and higher leukocyte count, lactic acid concentration, and PaCO2. After a single administration, gentamicin was first detectable in the pleural fluid at 60 min, whereas peak levels in empyema were observed at 180 min. Gentamicin persisted in the empyema longer than in blood. Animals treated with gentamicin only had 60% bacterial cure on day 7; those treated with gentamicin in an oxygen chamber had 100% cure on day 5 (P = 0.004). Low oxygen tension diminished the antibacterial efficacy of gentamicin in this model. An increase in oxygen tension improved the therapeutic results without alteration of the pharmacokinetics of gentamicin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3116920      PMCID: PMC174856          DOI: 10.1128/AAC.31.7.982

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Pleural fluid pH in parapneumonic effusions.

Authors:  D E Potts; D C Levin; S A Sahn
Journal:  Chest       Date:  1976-09       Impact factor: 9.410

2.  Empyema of the thorax then and now. A study of 122 cases over four decades.

Authors:  W C Weese; E R Shindler; I M Smith; S Rabinovich
Journal:  Arch Intern Med       Date:  1973-04

Review 3.  Pharmacokinetics of tissue penetration of antibiotics.

Authors:  T Bergan
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

Review 4.  The pseudomallei group: a review.

Authors:  C Howe; A Sampath; M Spotnitz
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

5.  Antimicrobial therapy of experimental intraabdominal sepsis.

Authors:  W M Weinstein; A B Onderdonk; J G Bartlett; T J Louie; S L Gorbach
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

6.  Pleural effusion: laboratory tests in 300 cases.

Authors:  A Hirsch; P Ruffie; M Nebut; J Bignon; J Chrétien
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

7.  Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.

Authors:  P D Lew; R Zubler; P Vaudaux; J J Farquet; F A Waldvogel; P H Lambert
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

8.  Empyema thoracis during a ten-year period. Analysis of 72 cases and comparison to a previous study (1952 to 1967).

Authors:  B Varkey; H D Rose; C P Kutty; J Politis
Journal:  Arch Intern Med       Date:  1981-12

Review 9.  The aminoglycosides.

Authors:  A M Ristuccia; B A Cunha
Journal:  Med Clin North Am       Date:  1982-01       Impact factor: 5.456

10.  Measurement of lactic acid in pleural fluid.

Authors:  I Brook
Journal:  Respiration       Date:  1980       Impact factor: 3.580

View more
  4 in total

1.  BTS guidelines for the management of pleural infection.

Authors:  C W H Davies; F V Gleeson; R J O Davies
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro.

Authors:  C König; H P Simmen; J Blaser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267

3.  Pleural infection-current diagnosis and management.

Authors:  Andrew Rosenstengel
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

4.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.